A human monoclonal antibody blocking SARS-CoV-2 infection
2020 · Nature Communications · 1,150 citations
https://doi.org/10.1038/s41467-020-16256-y
N
Nisreen M.A. Okba
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
11.7K
Citations
36
h-index
53
i10-index
Nisreen M.A. Okba is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies & COVID-19 Clinical Research Studies. The author has an h-index of 36, co-authored 63 publications.
ORCID: 0000-0002-2394-1079Papers by this author
worksA conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
2021 · Nature Communications · 204 citations
https://doi.org/10.1038/s41467-021-21968-w
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
2021 · Cell · 199 citations
https://doi.org/10.1016/j.cell.2021.01.035
MERS-coronavirus: From discovery to intervention
2016 · One Health · 67 citations
https://doi.org/10.1016/j.onehlt.2016.12.001
Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches
2017 · Current Opinion in Virology · 64 citations
https://doi.org/10.1016/j.coviro.2017.03.007
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
2022 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-022-31557-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat